You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The partners will evaluate several quality control assays for genome editing research, eventually creating a protocol for analyzing mutations in genomic DNA.
The UK-based firm plans to marry its core strengths with the probes and PCR platforms, and to build its sales force in the US.
LGC said it plans to use Douglas Scientific's PCR and qPCR platforms to provide customers with enhanced high-throughput genotyping and qPCR instruments.
The two companies will use KeyGene's technology for the genetic analysis of field and vegetable crops.
The investment firm says it will acquire LGC for an undisclosed amount.
LGC will offer TraitGenetics' SNP genotyping services using Illumina and Affymetrix array technologies to its global customers.
The three-year deal includes more than 100,000 pre-designed assays for public domain human SNPs.
Registered users of the IBP will have access to a range of genotyping services through LGS.
The acquisition will enable LGC to deliver product and laboratory service offerings for core qPCR and end-point PCR applications, as well as NGS.
Co-Diagnostics will license its CoPrimers technology to Biosearch to make, use, market, and sell the primer-dimer-reducing oligonucleotides.
Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.
Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.
New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.
In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.